VIGNA, Giovanni Battista
 Distribuzione geografica
Continente #
EU - Europa 4.551
NA - Nord America 4.538
AS - Asia 787
SA - Sud America 31
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 9.919
Nazione #
US - Stati Uniti d'America 4.522
IT - Italia 3.479
CN - Cina 448
UA - Ucraina 286
DE - Germania 233
TR - Turchia 233
GB - Regno Unito 140
SE - Svezia 92
FR - Francia 86
FI - Finlandia 74
SG - Singapore 66
PL - Polonia 51
BR - Brasile 26
CH - Svizzera 21
IE - Irlanda 15
BE - Belgio 14
CA - Canada 13
RO - Romania 11
NL - Olanda 10
ID - Indonesia 7
IN - India 7
GR - Grecia 6
RU - Federazione Russa 6
VN - Vietnam 6
ES - Italia 4
IR - Iran 4
AU - Australia 3
CZ - Repubblica Ceca 3
EU - Europa 3
AL - Albania 2
AR - Argentina 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
HK - Hong Kong 2
IQ - Iraq 2
JP - Giappone 2
KR - Corea 2
LU - Lussemburgo 2
MX - Messico 2
NO - Norvegia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HU - Ungheria 1
LI - Liechtenstein 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
TZ - Tanzania 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 9.919
Città #
Fairfield 608
Woodbridge 555
Houston 368
Jacksonville 344
Ann Arbor 326
Ashburn 285
Chandler 273
Seattle 261
Milan 236
Rome 227
Cambridge 216
Wilmington 201
Izmir 153
Beijing 112
Nanjing 96
Naples 81
Princeton 79
Bremen 77
Dearborn 57
Boardman 55
New York 51
Turin 43
Catania 42
Ferrara 42
Padova 41
Palermo 38
San Diego 36
Warsaw 36
Singapore 35
Bologna 34
Nanchang 31
Napoli 30
Shenyang 30
Bari 29
Shanghai 28
Florence 22
Hebei 22
Jiaxing 22
Verona 21
Addison 19
Mountain View 19
Redwood City 19
Ancona 18
Dallas 18
Genoa 18
Tianjin 17
Changsha 16
Falls Church 16
Parma 15
London 14
Southend 14
Brussels 13
Caserta 12
Norwalk 11
Taranto 11
Trieste 11
Cesena 10
Kunming 10
Nocera Inferiore 10
Torino 10
Andover 9
Auburn Hills 9
Des Moines 9
Guangzhou 9
Livorno 9
Nürnberg 9
Pettorazza Grimani 9
Pisa 9
Toronto 9
Zhengzhou 9
Brescia 8
Genova 8
Salerno 8
Altopascio 7
Cagliari 7
Jakarta 7
Ningbo 7
Vicenza 7
Arad 6
Castelfranco Veneto 6
Imola 6
Jinan 6
Lappeenranta 6
Lido di Fermo 6
Messina 6
Monza 6
Orange 6
Perugia 6
Pescara 6
Piemonte 6
Reggio Emilia 6
San Mateo 6
Siena 6
Trento 6
Udine 6
Venezia 6
Venice 6
Washington 6
Changchun 5
Civitanova Marche 5
Totale 5.823
Nome #
Tessuto adiposo e infiammazione sistemica. 2.292
Sindrome metabolica e infiammazione sistemica 1.116
Sindrome metabolica e steatosi epatica: rapporti, meccanismi e determinanti. 219
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study 159
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study 145
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 137
Dyslipidemias in the older subject: features, significance and treatment dilemmas 124
Dyslipidemia in peripheral vascular disease 121
Simvastatin, transdermal patch and oral estrogen-progestin preparation in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial 120
Short term effect of four different macronutrient oral loads on metalbolic profile and flow mediated vasodilatation in healthy young men 119
Iperlipoproteinemie e ipolipoproteinemie 118
Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers 117
The anti-atherogenic properties of HDL particles 115
null 114
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 113
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 112
Reversible hyperthyroidism and cardiomyopathy caused by consumption of iodocasein 111
Consensus Document on substitution therapy with DHEA in the elderly 111
Endothelial function and postprandial lipemia 110
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes 109
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 108
Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis 107
Chonobiological analysis of sudden death observed in an emergency department 107
Flow-Mediated dilation, carotid wall thickness and hdl function in subjects with hyperalphalipoproteinemia 106
Analbuminaemia: a natural model of metabolic compensatory systems 106
Pharmacotherapy of dyslipidemias in the adult population 106
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society 106
Disordini del metabolismo delle lipoproteine 104
Bilateral strio-pallido-dentate calcinosis (Fahr's disease): Report of seven cases and revision of literature 103
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - A post-hoc analysis of a Phase 3, single-arm, open-label trial 103
Advanced diagnostic support in lipidology project: Role for phenotypic and functional evaluation of lipoproteins in dyslipidemias 103
Transient massive hyperlipidaemia in a type 2 diabetic subject. 102
Iperchilomicronemia: Patologia negletta dagli internisti? [Hyperchylomicronemia: a neglected disease?] 101
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men 100
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 100
Role of antioxidants in atherosclerosis: Epidemiological and clinical update 99
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study) 98
Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia 98
Acidi Grassi 97
Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD) 96
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia 94
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort 94
null 93
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 93
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study 90
null 87
Plasma lipoproteins in soy-treated postmenopausal women: a double-blind,placebo-controlled trial 86
Hormonal Replacement Therapy and Lipids: Is Transdermal Norethisterone Acetate Better Than Oral Medroxyprogesterone Acetate? 85
Hypercholesterolemia and the ageing subject. 82
Cor Pulmonale 81
Circadian periodicity in suicidal behaviour and in opiate overdose syndrome 78
Chronobiology of symptomatic supraventricular paroxysmal tachycardia 77
Lipoproteine e dislipoproteinemie. 74
Adverse haematological effects of ticlopidine. A report of four cases 71
Raggiungimento del target terapeutico nei soggetti avviati al trattamento con statine in pratica clinica. Risultati dallo studio STAR (Statins Target Assessment in Real practice) 68
The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism 67
Effects of soy on lipoproteins in postmenopausal women: a double blind multicentre, placebo-controlled trial. 65
Lipoproteine 65
Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree 62
Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: The GAUSS-3 randomized clinical trial 62
Menopausal status, dyslipidemia and thyroid function: a cross sectional study. 59
Profilo lipidico plasmatico, marcatori di infiammazione e arteriopatia periferica degli arti inferiori: lo studio InCHIANTI 58
Testosterone replacement, cardiovascular system and risk factors in the aging male 58
Iperlipoproteinemie e ipolipoproteinemie 58
Low-dose simvastatin treatment in patients with moderate-grade familial hypercholesterolemia 57
Secondary prevention of myocardial infarction and long-term adherence to statin therapy: data from the Alarm2 investigation 56
Approccio cronobiologico alla colica renale 56
Oli di pesce 51
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease 51
Stato di salute e disabilità: risultati di una esperienza di valutazione geriatrica in una RSA 47
Lipid abnormalities in patients with extracoronary arteriosclerosis 45
null 44
Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol-3-phosphate dehydrogenase 1 deficiency 36
I trial clinici sull'uso delle statine nella cardiopatia ischemica 32
Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case-control study 22
Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial. 20
Hypolipidemic drugs in elderly subjects: Indications and limits 19
LIPOPROTEINA (A) E RISCHIO DI MORTE PER TUTTE LE CAUSE IN SOGGETTI ANZIANI FREE-LIVING: LO STUDIO InCHIANTI FOLLOW-UP 18
Risk of hospitalization for upper gastrointestinal tract bleeding 9
Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia. 9
Totale 10.111
Categoria #
all - tutte 29.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.307
Totale 31.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019395 0 0 0 0 0 0 0 0 0 0 0 395
2019/20201.793 278 64 86 233 130 195 160 173 150 159 98 67
2020/20211.456 117 80 107 165 82 142 57 136 66 180 159 165
2021/20221.423 55 98 81 114 93 100 85 142 111 128 108 308
2022/20231.614 171 88 115 115 224 166 153 130 162 60 134 96
2023/20241.456 87 97 95 82 85 149 151 116 95 144 161 194
Totale 10.111